Bromide

Bromide

SCHEMBL4657453

Br.CC[C@H](C)[C@H](N)C(=O)NC(=O)c1ccc2ccccc2c1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC2 Q92769 2/20 0.48
METAP2 P50579 5/20 0.47
METAP1 P53582 3/20 0.47
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ELANE P08246 1/20 0.43
MME P08473 1/20 0.42
ACE P12821 1/20 0.42
CPA1 P15085 1/20 0.42
ACE2 Q9BYF1 1/20 0.42
DPP8 Q6V1X1 2/20 0.42
DPP9 Q86TI2 2/20 0.42
DPP7 Q9UHL4 2/20 0.42
DPP4 P27487 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2545018 0.85 METAP2 (0.49) HDAC3HDAC1HDAC2METAP2METAP1
SCHEMBL4267098 0.82 METAP2 (0.51) HDAC3HDAC1HDAC2METAP2METAP1
SCHEMBL8490097 0.82 ALDH1A1 (0.48) NPC1RAB9AALDH1A1SMN1; SMN2DPP8
Bromide SCHEMBL5891506 0.79 SMN1; SMN2 (0.55) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL985997 0.79 LARS1 (0.58) HDAC3HDAC1HDAC2METAP2METAP1
Hydrochloric Acid SCHEMBL8669233 0.78 LARS1 (0.57) HDAC3HDAC1HDAC2METAP2METAP1
Cystine SCHEMBL9132888 0.76 METAP2 (0.47) HDAC3HDAC1HDAC2METAP2METAP1
SCHEMBL7043430 0.76 METAP2 (0.46) HDAC3HDAC1HDAC2METAP2METAP1
SCHEMBL9390095 0.75 METAP2 (0.49) HDAC3HDAC1HDAC2METAP2NPC1
SCHEMBL6828289 0.74 NAMPT (0.57) METAP2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1018345-B1 WATER SOLUBLE DRY COMPOSITIONS OTSUKA PHARMA CO LTD (JP) 2008-12-10 EP disclosed
EP-1254944-B1 DRY COMPOSITIONS CONTAINING HYDROPHOBIC AMINO ACID OTSUKA PHARMA CO LTD (JP) 2007-03-28 EP disclosed
US-20030045481-A1 Dry compositions containing hydrophobic amino acid OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2003-03-06 US disclosed
US-6479048-B2 FOAM INHIBITOR COMPRISING HYDROPHOBIC AMINO ACID WHICH IS SUITABLE FOR INHIBITING FOAMING INDUCED WHEN DISSOLVING A DRY COMPOSITION CONTAINING SACCHARIDE; PREFERABLY HAS A HYDROPATHY INDEX OF NOT LESS THAN 2. OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-11-12 US disclosed
EP-1254944-A1 DRY COMPOSITIONS CONTAINING HYDROPHOBIC AMINO ACID OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-11-06 EP disclosed
US-6337067-B1 FOR INHIBITING FOAMING CAUSED WHEN DISSOLVING A CONVENTIONAL DRY COMPOSITION CONTAINING A SACCHARIDE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-01-08 US disclosed
US-20010049361-A1 Water-soluble dry compositions OTSUKA PHARMACEUTICAL CO., LTD. 2001-12-06 US disclosed
EP-1018345-A1 WATER SOLUBLE DRY COMPOSITIONS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-07-12 EP disclosed